• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.

作者信息

Brugaletta Salvatore, Gori Tommaso, Low Adrian F, Tousek Petr, Pinar Eduardo, Gomez-Lara Josep, Ortega-Paz Luis, Schulz Eberhard, Chan Mark Y, Kocka Viktor, Hurtado Jose, Gomez-Hospital Joan Antoni, Giacchi Giuseppe, Münzel Thomas, Lee Chi-Hang, Cequier Angel, Valdés Mariano, Widimsky Petr, Serruys Patrick W, Sabaté Manel

机构信息

Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

Deutsches Zentrum für Herz und Kreislauf Forschung, Standort Rhein-Main, Mainz, Germany.

出版信息

Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7.

DOI:10.1016/j.ijcard.2016.04.016
PMID:27096965
Abstract
摘要

相似文献

1
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.生物可吸收血管支架与依维莫司洗脱金属支架用于ST段抬高型心肌梗死的比较（BVS EXAMINATION研究）：倾向评分匹配比较的2年结果
Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7.
2
Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study.与非生物可吸收药物洗脱支架相比，依维莫司洗脱生物可吸收血管支架（BVS）在ST段抬高型心肌梗死（STEMI）治疗中的疗效——一项对比研究。
Cardiovasc Revasc Med. 2016 Apr-May;17(3):151-4. doi: 10.1016/j.carrev.2016.01.004. Epub 2016 Jan 21.
3
Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study.依维莫司洗脱生物可吸收血管支架治疗急性心肌梗死患者的初步经验：与金属药物洗脱支架的倾向性匹配比较——BVS STEMI首次研究的18个月随访
EuroIntervention. 2016 May 17;12(1):30-7. doi: 10.4244/EIJV12I1A6.
4
Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study.协同支架与依维莫司洗脱生物可吸收血管支架植入急性心肌梗死后的再内皮化：COVER-AMI研究
Trials. 2019 Apr 11;20(1):210. doi: 10.1186/s13063-019-3293-8.
5
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗（PCI）时使用 Absorb 依维莫司洗脱生物可吸收血管支架（Absorb BVS）与可降解聚合物依维莫司洗脱金属支架（XIENCE）的动脉愈合情况：随机 TROFI II 研究的原理和设计。
EuroIntervention. 2016 Jul 20;12(4):482-9. doi: 10.4244/EIJY15M08_03.
6
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.依维莫司洗脱生物可吸收血管支架治疗糖尿病患者 1 年的临床结果：ABSORB 和 SPIRIT 试验的汇总分析。
JACC Cardiovasc Interv. 2014 May;7(5):482-93. doi: 10.1016/j.jcin.2014.01.155. Epub 2014 Apr 16.
7
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.依维莫司洗脱生物可吸收支架与依维莫司洗脱支架的1年结局：GHOST-EU和XIENCE V美国注册研究的倾向匹配比较
JACC Cardiovasc Interv. 2016 Mar 14;9(5):440-9. doi: 10.1016/j.jcin.2015.10.042. Epub 2016 Jan 6.
8
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中，435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局：与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。
JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.
9
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原位冠状动脉病变所致缺血性心脏病的随机对照研究：ABSORB II试验的2年临床结果
EuroIntervention. 2016 Oct 20;12(9):1102-1107. doi: 10.4244/EIJY16M08_01.
10
Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis.急性心肌梗死期间植入的生物可吸收血管支架或金属支架中血栓性脱垂负担的差异：雪鞋效应：最大覆盖面积分析的见解
Int J Cardiol. 2016 Oct 1;220:802-8. doi: 10.1016/j.ijcard.2016.06.077. Epub 2016 Jun 23.

引用本文的文献

1
Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction.在现实世界中ST段抬高型心肌梗死患者中，依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较。
Postepy Kardiol Interwencyjnej. 2020 Mar;16(1):49-57. doi: 10.5114/aic.2020.93912. Epub 2020 Apr 3.
2
Mid-term outcomes of bioresorbable vascular scaffolds vs second-generation drug-eluting stents in patients with acute coronary syndromes: A systematic review and meta-analysis.生物可吸收血管支架与第二代药物洗脱支架治疗急性冠脉综合征患者的中期疗效：一项系统评价和荟萃分析
Medicine (Baltimore). 2020 Mar;99(10):e19458. doi: 10.1097/MD.0000000000019458.
3
Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study.ST段抬高型心肌梗死患者生物可吸收支架植入术：PRAGUE-19研究的5年影像学亚分析
J Transl Med. 2020 Jan 30;18(1):33. doi: 10.1186/s12967-020-02230-1.
4
Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.Absorb BVS 与第二代 DES 的中期结果：系统评价和荟萃分析。
PLoS One. 2018 May 9;13(5):e0197119. doi: 10.1371/journal.pone.0197119. eCollection 2018.
5
Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?急性冠状动脉综合征是生物可吸收血管支架植入的理想情况吗？
J Thorac Dis. 2017 Aug;9(Suppl 9):S969-S978. doi: 10.21037/jtd.2017.06.136.
6
Bioresorbable vascular scaffolds for complex coronary anatomies: "Icarus' flight" for interventional cardiologists?用于复杂冠状动脉解剖结构的生物可吸收血管支架：介入心脏病学家的“伊卡洛斯之飞”？
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S98-S101. doi: 10.21037/cdt.2017.01.10.
7
Contemporary management of ST-segment elevation myocardial infarction.ST段抬高型心肌梗死的当代管理
Intern Emerg Med. 2016 Dec;11(8):1107-1113. doi: 10.1007/s11739-016-1550-3. Epub 2016 Oct 6.